Promoting the Formation and Stabilization of G-Quadruplex by Dinuclear RuII Complex Ru2(obip)L4

Studies on synthesis, characterization, and G-quadruplex binding of Ru(II) complexes containing two dppz ligands

In this work, the interaction between the guanine-rich single-strand oligomer AG(3)(T(2)AG(3))(3) quadruplex and two Ru(II) complexes, [Ru(L(1))(dppz)(2)](PF(6))(4) (1) and [Ru(L(2))(dppz)(2)](PF(6))(4) (2) (L(1) = 5,5'-di(1-(trimethylammonio)methyl)-2,2'-dipyridyl cation, L(2) = 5,5'-di(1-(triethylammonio)methyl)-2,2'-dipyridyl cation, dppz = dipyrido[3,2-a:2',3'-c] phenazine), has been studied by UV-Visible, fluorescence, DNA melting, and circular dichroism in K(+) buffer. The two complexes after binding to G-quadruplex have shown different DNA stability and fluorescence enhancement. The results show that both complexes can induce the stabilization of quadruplex DNA. ΔT(m) values of complexes 1 and 2 at [Ru]/[DNA] ratio of 1:1 were 9.4 and 7.0, respectively. Binding stoichiometry along with the quadruplex was investigated through a luminescence-based Job plot. The major inflection points for complexes 1 and 2 were 0.49 and 0.46, respectively. The data were consistent with the binding mode at a [quadruplex]/[complex] ratio of 1:1. In addition, the conformation of G-quadruplex was not changed by the complexes at the high ionic strength of K(+) buffer.

Structure-based design of platinum(II) complexes as c-myc oncogene down-regulators and luminescent probes for G-quadruplex DNA

A series of platinum(II) complexes with tridentate ligands was synthesized and their interactions with G-quadruplex DNA within the c-myc gene promoter were evaluated. Complex 1, which has a flat planar 2,6-bis(benzimidazol-2-yl)pyridine (bzimpy) scaffold, was found to stabilize the c-myc G-quadruplex structure in a cell-free system. An in silico G-quadruplex DNA model has been constructed for structure-based virtual screening to develop new Pt(II)-based complexes with superior inhibitory activities. By using complex 1 as the initial structure for hit-to-lead optimization, bzimpy and related 2,6-bis(pyrazol-3-yl)pyridine (dPzPy) scaffolds containing amine side-chains emerge as the top candidates. Six of the top-scoring complexes were synthesized and their interactions with c-myc G-quadruplex DNA have been investigated. The results revealed that all of the complexes have the ability to stabilize the c-myc G-quadruplex. Complex 3 a ([Pt(II)L2R](+); L2=2,6-bis[1-(3-piperidinepropyl)-1H-enzo[d]imidazol-2-yl]pyridine, R=Cl) displayed the strongest inhibition in a cell-free system (IC(50)=2.2 microM) and was 3.3-fold more potent than that of 1. Complexes 3 a and 4 a ([Pt(II)L3R](+); L3=2,6-bis[1-(3-morpholinopropyl)-1H-pyrazol-3-yl]pyridine, R=Cl) were found to effectively inhibit c-myc gene expression in human hepatocarcinoma cells with IC(50) values of approximately 17 microM, whereas initial hit 1 displayed no significant effect on gene expression at concentrations up to 50 microM. Complexes 3 a and 4 a have a strong preference for G-quadruplex DNA over duplex DNA, as revealed by competition dialysis experiments and absorption titration; 3 a and 4 a bind G-quadruplex DNA with binding constants (K) of approximately 10(6)-10(7) dm(3) mol(-1), which are at least an order of magnitude higher than the K values for duplex DNA. NMR spectroscopic titration experiments and molecular modeling showed that 4 a binds c-myc G-quadruplex DNA through an external end-stacking mode at the 3'-terminal face of the G-quadruplex. Intriguingly, binding of c-myc G-quadruplex DNA by 3 b is accompanied by an increase of up to 38-fold in photoluminescence intensity at lambda(max)=622 nm.

Interaction of metal complexes with G-quadruplex DNA

Guanine-rich sequences of DNA can assemble into tetrastranded structures known as G-quadruplexes. It has been suggested that these secondary DNA structures could be involved in the regulation of several key biological processes. In the human genome, guanine-rich sequences with the potential to form G-quadruplexes exist in the telomere as well as in promoter regions of certain oncogenes. The identification of these sequences as novel targets for the development of anticancer drugs has sparked great interest in the design of molecules that can interact with quadruplex DNA. While most reported quadruplex DNA binders are based on purely organic templates, numerous metal complexes have more recently been shown to interact effectively with this DNA secondary structure. This Review provides an overview of the important roles that metal complexes can play as quadruplex DNA binding molecules, highlighting the unique properties metals can confer to these molecules.

Stabilization of G-quadruplex DNA with platinum(II) Schiff base complexes: luminescent probe and down-regulation of c-myc oncogene expression

The interactions of a series of platinum(II) Schiff base complexes with c-myc G-quadruplex DNA were studied. Complex [PtL(1a)] (1 a; H(2)L(1a)=N,N'-bis(salicylidene)-4,5-methoxy-1,2-phenylenediamine) can moderately inhibit c-myc gene promoter activity in a cell-free system through stabilizing the G-quadruplex structure and can inhibit c-myc oncogene expression in cultured cells. The interaction between 1 a and G-quadruplex DNA has been examined by (1)H NMR spectroscopy. By using computer-aided structure-based drug design for hit-to-lead optimization, an in silico G-quadruplex DNA model has been constructed for docking-based virtual screening to develop new platinum(II) Schiff base complexes with improved inhibitory activities. Complex [PtL(3)] (3; H(2)L(3)=N,N'-bis{4-[1-(2-propylpiperidine)oxy]salicylidene}-4,5-methoxy-1,2-phenylenediamine) has been identified with a top score in the virtual screening. This complex was subsequently prepared and experimentally tested in vitro for its ability to stabilize or induce the formation of the c-myc G-quadruplex. The inhibitory activity of 3 (IC(50)=4.4 muM) is tenfold more than that of 1 a. The interaction between 1 a or 3 with c-myc G-quadruplex DNA has been examined by absorption titration, emission titration, molecular modeling, and NMR titration experiments, thus revealing that both 1 a and 3 bind c-myc G-quadruplex DNA through an external end-stacking mode at the 3' terminal face of the G-quadruplex. Such binding of G-quadruplex DNA with 3 is accompanied by up to an eightfold increase in the intensity of photoluminescence at lambda(max)=652 nm. Complex 3 also effectively down-regulated the expression of c-myc in human hepatocarcinoma cells.

Interaction of [Ru(bpy)2(dppz)]2+ with human telomeric DNA: preferential binding to G-quadruplexes over i-motif

Inspired by the enormous importance attributed to the structure and function of human telomeric DNA, we focus our attention on the interaction of [Ru(bpy)(2)(dppz)](2+) with the guanine-rich single-strand oligomer 5'-AGGGTTAGGGTTAGGGTTAGGG-3' (22AG) and the complementary cytosine-rich strand (22CT). In Na(+) buffer, 22AG may adopt an antiparallel basket quadruplex, whereas, it favours a mixed parallel/antiparallel structure in K(+) buffer. 22CT may self-associate at acidic pH into an i-motif. In this paper, the interaction between [Ru(bpy)(2)(dppz)](2+) and each unusual DNA was evaluated. It was interesting that [Ru(bpy)(2)(dppz)](2+) could promote the human telomeric repeat 22AG to fold into intramolecular antiparallel G-quadruplex without any other cations. What's more, [Ru(bpy)(2)(dppz)](2+) was found to have a strong preference for binding to G-quadruplexes that were induced through either Na(+) or K(+), while weak binding to i-motif was observed. The results also indicated that [Ru(bpy)(2)(dppz)](2+) could serve as a prominent molecular "light switch" for both G-quadruplexes, revealing a potential application of the title complex in luminescent signaling of G-quadruplex DNA.

Synthesis, structural characterization, and quadruplex DNA binding studies of platinum(II)-terpyridine complexes

Three new substituted terpyridine ligands and their corresponding platinum(II) complexes have been prepared and fully characterized (including the X-ray crystal structures of two of the complexes). These compounds have shown to stack via pi-pi interactions both in the solid state and in solution. The interactions of these compounds with quadruplex DNA (both HTelo and c-myc sequences) have been studied by fluorescent indicator displacement (FID) assays, surface plasmon resonance (SPR), and in one case by circular dichroism (CD). The complexes have shown to interact strongly with quadruplex DNA (with binding constants of ca. 10(6) and DC(50) values between 2.24 and 0.26, as determined by SPR and FID, respectively). We have also investigated the interaction between the complexes and a sequence of duplex DNA to gain some insight into the selectivity of the compounds for quadruplex structures. FID and SPR studies have shown that the complexes have a modest selectivity (1 order of magnitude) for quadruplex, particularly c-myc, versus duplex DNA.

Homogeneous selecting of a quadruplex-binding ligand-based gold nanoparticle fluorescence resonance energy transfer assay

G-quadruplexes are higher-order DNA and RNA structures formed from G-rich sequences that are built around tetrads of hydrogen-bonded guanine bases. There is considerable interest in the design of ligands that target G-quadruplex DNA because of their potential anticancer activity. We designed a fluorescence resonance energy transfer (FRET) system to identify molecules that stabilize G-quadruplexes in a homogeneous medium using unmodified gold nanoparticles (GNPs) as a fluorescence quencher. The assay exploits the different adsorption abilities of GNPs for single-stranded DNA and double-stranded DNA. Fluorescein-tagged probe DNA adsorbed onto the surface of GNPs can quench the fluorescence of a DNA probe. Intramolecular folding of an oligonucleotide of the human telomeric sequence into a G-quadruplex structure led to fluorescence enhancement in the presence of quadruplex-binding ligands. G-quadruplex formation, induced by specific binding of GDNA ligands, was investigated by CD measurements. Melting of the G-quadruplex was monitored in the presence of putative G-quadruplex-binding molecules by measuring the absorbance at 295 nm. Two series of natural drugs were studied, and flavonoids were shown to increase the melting temperature of the G-quadruplex. This increase in the Tm value was well-correlated with an increase in FRET efficiency. The combined data from fluorescence measurements and melting experiments indicate that the FRET approach offers a simple, sensitive, and effective method to identify ligands with potential anticancer activity.

Platinum(II) complexes with dipyridophenazine ligands as human telomerase inhibitors and luminescent probes for G-quadruplex DNA

A series of platinum(II) complexes containing dipyridophenazine (dppz) and C-deprotonated 2-phenylpyridine (N-CH) ligands were prepared and assayed for G-quadruplex DNA binding activities. [PtII(dppz-COOH)(N-C)]CF3SO3 (1; dppz-COOH = 11-carboxydipyrido[3,2-a:2',3'-c]phenazine) binds G-quadruplex DNA through an external end-stacking mode with a binding affinity of approximately 10(7) dm3 mol-1. G-quadruplex DNA binding is accompanied by up to a 293-fold increase in the intensity of photoluminescence at lambdamax = 512 nm. Using a biotinylated-primer extension telomerase assay, 1 was shown to be an effective inhibitor of human telomerase in vitro, with a telIC50 value of 760 nM.

N2-functionalized blue luminescent guanosines by 2,2'-dipyridylamino and 2-(2'-pyridyl)benzimidazolyl chelate groups and their interactions with Zn(II) ions

The syntheses of new blue luminescent N(2)-modified guanosine derivatives with chromophores p-4,4'-biphenyl-NPh2 (1a), p-4,4'-biphenyl-N(2-py)2 (1b), and p-4,4'-biphenyl-2-(2'-pyridyl)benzimidazolyl (1c), respectively, have been achieved. These new N(2)-guanosines are moderate blue emitters with lambda(max) = 395 nm (1a), 370 nm (1b), and 403 nm (1c) and Phi = 0.13, 0.07, and 0.10 in tetrahydrofuran, respectively. Spectroscopic studies and density-functional theory calculations established that the guanine moiety and the new chromophore in all three molecules are involved in the luminescent process. We have also established that guanosines 1a-1c can interact with metal ions such as Zn(II). The interactions of Zn(II) ions with the three guanosines were examined via absorption, fluorescence, circular dichroism (CD), and NMR spectroscopic analyses. We have found that these guanosines display a distinct fluorescent response toward Zn(II) ions which can be attributed to the presence of the chelate chromophore N(2-py)2 in 1b and 2-py-benzimidazolyl in 1c. For 1a and 1b, the addition of Zn(II) ions causes straight fluorescent quenching while for 1c the addition of Zn(II) ions causes quenching initially, which is followed by a distinct spectral red shift and the intensity enhancement of the new emission peak. NMR and CD studies demonstrated that the Zn(II) ions bind preferentially to the guanine moiety in 1a and 1b but to the 2-(2'-py)benzimidazolyl chelate site in 1c. Moreover, the anion-dependent CD response of 1a-1c toward Zn(II) salts points to the possible involvement of intramolecular hydrogen bonding between the acetate bound to the Zn(II) ion and the hydroxyl groups of the guanosine.